Delivery Order SPE2DB22D2211-SPE2DB24FNEE4
- Not listed
- This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. The contract is a firm fixed price delivery order awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $4,317.40 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite...
- This federal contract award is for the supply of IMOVAX rabies vaccine vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,158.70, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 28, 2024. The contract is a delivery order with a firm fixed price and a completion date of July 1, 2024. Amerisourcebergen, through its Corporate Office Division, is the prime contractor and there is no...
- This federal contract award is for the procurement of IMOVAX RABIES VACCINE VIALS by the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,421.14 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 10, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 16, 2025. The contract has a firm fixed price of $2,004.75 and a completion date of January 17, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- The federal contract award is to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract has an award value of $1,295.22 and a performance period through August 16, 2024. It is a firm-fixed-price delivery order contract. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC...
- This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA). The $1,295.22 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies. The contract has an ultimate completion date of October 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of IMOVAX Rabies vaccine vials to the Defense Logistics Agency (DLA). The contract, valued at $1,339.98, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of December 10, 2024. The contract is a delivery order and is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
- This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price of $7,360.76 and has an ultimate completion date of May 23, 2025. This award is not associated with a set-aside program. Amerisourcebergen...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of IMOVAX RABIES VACCINE VIALS to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $2,590.44 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization that serves as a key supplier of pharmaceuticals and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX rabies vaccine vials. The contract has a ceiling value of $1,942.83 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. In addition to this delivery order, Amerisourcebergen Drug...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FNEE4Delivery Order
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $4,533.27 and a performance period through April 11, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 4/10/24 |